Product Images Lamivudine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Lamivudine NDC 31722-754 by Camber Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
camber1
camber2
lamivudine1
The text describes the proportions of subjects with HIV-1 RNA less than 400 copies/mL at different treatment times (in weeks) for two different doses of Lamivudine. The first dose is 150 mg taken twice daily, while the second dose is 300 mg taken once daily. The graph shows the data for up to 48 weeks of treatment.*
lamivudine150mg
lamivudine300mg
lamivudinestruc
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.